177 related articles for article (PubMed ID: 25588868)
1. SEW2871 protects from experimental colitis through reduced epithelial cell apoptosis and improved barrier function in interleukin-10 gene-deficient mice.
Dong J; Wang H; Zhao J; Sun J; Zhang T; Zuo L; Zhu W; Gong J; Li Y; Gu L; Li J
Immunol Res; 2015 Mar; 61(3):303-11. PubMed ID: 25588868
[TBL] [Abstract][Full Text] [Related]
2. Oral treatment with SEW2871, a sphingosine-1-phosphate type 1 receptor agonist, ameliorates experimental colitis in interleukin-10 gene deficient mice.
Dong J; Wang H; Wu G; Zhao J; Zhang L; Zuo L; Zhu W; Gong J; Li Y; Gu L; Li J
Clin Exp Immunol; 2014 Jul; 177(1):94-101. PubMed ID: 24611843
[TBL] [Abstract][Full Text] [Related]
3. Anti-mouse CD52 monoclonal antibody ameliorates intestinal epithelial barrier function in interleukin-10 knockout mice with spontaneous chronic colitis.
Wang H; Dong J; Shi P; Liu J; Zuo L; Li Y; Gong J; Gu L; Zhao J; Zhang L; Zhang W; Zhu W; Li N; Li J
Immunology; 2015 Feb; 144(2):254-62. PubMed ID: 25087772
[TBL] [Abstract][Full Text] [Related]
4. DHA protects against experimental colitis in IL-10-deficient mice associated with the modulation of intestinal epithelial barrier function.
Zhao J; Shi P; Sun Y; Sun J; Dong JN; Wang HG; Zuo LG; Gong JF; Li Y; Gu LL; Li N; Li JS; Zhu WM
Br J Nutr; 2015 Jul; 114(2):181-8. PubMed ID: 26104043
[TBL] [Abstract][Full Text] [Related]
5. Laquinimod ameliorates spontaneous colitis in interleukin-10-gene-deficient mice with improved barrier function.
Sun J; Shen X; Dong J; Zhao J; Zuo L; Wang H; Li Y; Zhu W; Gong J; Li J
Int Immunopharmacol; 2015 Dec; 29(2):423-432. PubMed ID: 26603637
[TBL] [Abstract][Full Text] [Related]
6. Dietary Non-digestible Polysaccharides Ameliorate Intestinal Epithelial Barrier Dysfunction in IL-10 Knockout Mice.
Wang H; Shi P; Zuo L; Dong J; Zhao J; Liu Q; Zhu W
J Crohns Colitis; 2016 Sep; 10(9):1076-86. PubMed ID: 26944415
[TBL] [Abstract][Full Text] [Related]
7. A novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient mice.
Song J; Matsuda C; Kai Y; Nishida T; Nakajima K; Mizushima T; Kinoshita M; Yasue T; Sawa Y; Ito T
J Pharmacol Exp Ther; 2008 Jan; 324(1):276-83. PubMed ID: 17898319
[TBL] [Abstract][Full Text] [Related]
8. The Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor 2 Axis in Intestinal Epithelial Cells Regulates Intestinal Barrier Function During Intestinal Epithelial Cells-CD4+T-Cell Interactions.
Chen T; Lin R; Jin S; Chen R; Xue H; Ye H; Huang Z
Cell Physiol Biochem; 2018; 48(3):1188-1200. PubMed ID: 30045015
[TBL] [Abstract][Full Text] [Related]
9. Peiminine ameliorates Crohn's disease-like colitis by enhancing the function of the intestinal epithelial barrier through Nrf2/HO1 signal.
Qiu Q; Geng Z; Wang L; Zuo L; Deng M; Zhang H; Yang Y; Wang Y; Zhao Z; Wen H; Wang Q; Wang Y; He X; Li J; Wang Y; Zhang X; Liu M; Song X
Int Immunopharmacol; 2024 Jul; 136():112380. PubMed ID: 38850790
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine-1-phosphate receptor 1 agonist SEW2871 prolongs heterotopic heart allograft survival in mice.
Ni Q; Yuan B; Liu T; Lan F; Luo X; Lu X; Huang P; Dai L; Jin X; Yin H
Int Immunopharmacol; 2015 May; 26(1):37-42. PubMed ID: 25776899
[TBL] [Abstract][Full Text] [Related]
11. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis.
Zhao HW; Yue YH; Han H; Chen XL; Lu YG; Zheng JM; Hou HT; Lang XM; He LL; Hu QL; Dun ZQ
World J Gastroenterol; 2017 Feb; 23(6):999-1009. PubMed ID: 28246473
[TBL] [Abstract][Full Text] [Related]
12. Magnolin inhibits intestinal epithelial cell apoptosis alleviating Crohn's disease-like colitis by suppressing the PI3K/AKT signalling pathway.
Zhang M; Song X; Liu S; Zhang N; Yang M; Gao P; Geng Z; Zuo L; Zhang X; Wang L; Wang Y; Li J; Hu J
Int Immunopharmacol; 2024 Jun; 134():112181. PubMed ID: 38733829
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of a new immunosuppressive agent, everolimus, on interleukin-10 gene-deficient mice with colitis.
Matsuda C; Ito T; Song J; Mizushima T; Tamagawa H; Kai Y; Hamanaka Y; Inoue M; Nishida T; Matsuda H; Sawa Y
Clin Exp Immunol; 2007 May; 148(2):348-59. PubMed ID: 17437423
[TBL] [Abstract][Full Text] [Related]
14. Arjunolic acid protects the intestinal epithelial barrier, ameliorating Crohn's disease-like colitis by restoring gut microbiota composition and inactivating TLR4 signalling.
Zhang Z; Zuo L; Song X; Wang L; Zhang Y; Cheng Y; Huang J; Zhao T; Yang Z; Zhang H; Li J; Zhang X; Geng Z; Wang Y; Ge S; Hu J
Phytomedicine; 2024 Jan; 123():155223. PubMed ID: 38134862
[TBL] [Abstract][Full Text] [Related]
15. Autophagy induction by rapamycin ameliorates experimental colitis and improves intestinal epithelial barrier function in IL-10 knockout mice.
Zhao J; Wang H; Yang H; Zhou Y; Tang L
Int Immunopharmacol; 2020 Apr; 81():105977. PubMed ID: 31677991
[TBL] [Abstract][Full Text] [Related]
16. Antrum Mucosal Protein-18 Peptide Targets Tight Junctions to Protect and Heal Barrier Structure and Function in Models of Inflammatory Bowel Disease.
Chen P; Bakke D; Kolodziej L; Lodolce J; Weber CR; Boone DL; Toback FG
Inflamm Bowel Dis; 2015 Oct; 21(10):2393-2402. PubMed ID: 26197453
[TBL] [Abstract][Full Text] [Related]
17. Inflammation-induced Occludin Downregulation Limits Epithelial Apoptosis by Suppressing Caspase-3 Expression.
Kuo WT; Shen L; Zuo L; Shashikanth N; Ong MLDM; Wu L; Zha J; Edelblum KL; Wang Y; Wang Y; Nilsen SP; Turner JR
Gastroenterology; 2019 Nov; 157(5):1323-1337. PubMed ID: 31401143
[TBL] [Abstract][Full Text] [Related]
18. Bryostatin-1 ameliorated experimental colitis in Il-10
Zuo L; Li J; Ge S; Ge Y; Shen M; Wang Y; Zhou C; Wu R; Hu J
J Cell Mol Med; 2019 Aug; 23(8):5588-5599. PubMed ID: 31251471
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.
Heller F; Florian P; Bojarski C; Richter J; Christ M; Hillenbrand B; Mankertz J; Gitter AH; Bürgel N; Fromm M; Zeitz M; Fuss I; Strober W; Schulzke JD
Gastroenterology; 2005 Aug; 129(2):550-64. PubMed ID: 16083712
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of a new lymphocyte homing reagent FTY720 in interleukin-10 gene-deficient mice with colitis.
Mizushima T; Ito T; Kishi D; Kai Y; Tamagawa H; Nezu R; Kiyono H; Matsuda H
Inflamm Bowel Dis; 2004 May; 10(3):182-92. PubMed ID: 15290910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
